Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Toxins01:36

Types of Toxins

3.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K
Bacterial Toxins01:12

Bacterial Toxins

117
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
117
Vaccines01:21

Vaccines

64
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
64
Diphtheria01:28

Diphtheria

165
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
165
Vaccinations01:51

Vaccinations

43.7K
Overview
43.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational bottlenecks for biohybrid microrobots.

Science robotics·2026
Same author

Light-switchable swarming of biohybrid microrobots.

Science advances·2026
Same author

A STING-adjuvanted outer membrane vesicle nanoparticle vaccine vs. <i>Klebsiella pneumoniae</i> elicits broad capsule-type cross-protection.

PNAS nexus·2026
Same author

Integrating Experiments and Simulations to Uncover Size-Dependent Bioactivity in Cellular Nanodiscs.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Light-Triggered Accelerated Degradation of Surface-Bound Chemical Agents.

Journal of the American Chemical Society·2026
Same author

Cellular Nanoparticle-Probiotic Biohybrid for Multimodal Oral Therapy of Food Allergy.

ACS nano·2026
Same journal

Emerging metallic nanotechnology platforms for cancer sensing and imaging.

Nano today·2026
Same journal

The landscape of nanomedical clinical trials.

Nano today·2026
Same journal

Nanofluidic delivery implant sustains localization and maximizes efficacy of intratumoral immunotherapy.

Nano today·2026
Same journal

Peroxidase-catalyzed proximity labeling to survey the proteome of nanomaterial-cell interface during macropinocytosis-mediated internalization.

Nano today·2025
Same journal

Efficient Intracellular Delivery of CRISPR-Cas9 Ribonucleoproteins Using Dendrimer Nanoparticles for Robust Genomic Editing.

Nano today·2025
Same journal

Lymph node targeting of cyclosporine ameliorates ocular manifestations in a mouse model of systemic lupus erythematosus (SLE) via PD-L1.

Nano today·2024
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

7.9K

Nanotoxoid Vaccines.

Che-Ming J Hu1, Liangfang Zhang1

  • 1Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, United States.

Nano Today
|October 7, 2014
PubMed
Summary
This summary is machine-generated.

Novel nanoparticle vaccines safely deliver intact toxins to train the immune system, offering a new approach to combat bacterial infections like MRSA. This method enhances vaccine potency and reduces toxin virulence.

Keywords:
NanomedicineNanoparticle detainmentNanotechnologyNanotoxoidToxin vaccination

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.9K
Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
14:29

Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy

Published on: October 1, 2012

11.5K

Related Experiment Videos

Last Updated: Apr 23, 2026

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

7.9K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.9K
Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
14:29

Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy

Published on: October 1, 2012

11.5K

Area of Science:

  • Immunology
  • Nanotechnology
  • Vaccinology

Background:

  • Vaccines train the immune system using weakened microbes or toxins.
  • Nanoparticles enhance vaccine potency and safety.
  • Current toxoid vaccines alter toxins, reducing antigenicity.

Purpose of the Study:

  • To develop a novel nanoparticle-based vaccine platform.
  • To deliver intact, non-denatured toxins for immune processing.
  • To create effective anti-toxin responses against membrane-damaging toxins.

Main Methods:

  • Utilizing biomimetic nanoparticles cloaked in biological membranes.
  • Sequestering membrane-active toxins within nanoparticles to neutralize toxicity.
  • Facilitating intracellular delivery of toxin-nanoparticle complexes.

Main Results:

  • Demonstrated safe delivery of intact, non-denatured protein toxins.
  • Achieved potent anti-toxin immune responses.
  • Developed nanotoxoid formulations effective against MRSA and Group A Streptococcus.

Conclusions:

  • Nanoparticle-based sequestration offers a novel strategy for toxoid vaccine design.
  • Preserving toxin structure enhances immune processing and anti-toxin responses.
  • This approach provides a viable anti-virulence measure for challenging bacterial infections.